AntineoplasticsLack of efficacy and off-label use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1920卷 / 1期

关键词：

D O I：

10.1007/s40278-022-21595-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：58 / 58

相关论文

共 50 条

[21] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2021, 1873 (1) : 178 - 178
[22] Antibacterials/methylprednisoloneLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2022, 1918 (1) : 50 - 50
[23] DaratumumabLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2022, 1925 (1) : 204 - 204
[24] Methylprednisolone/fampridineLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2021, 1884 (1) : 275 - 275
[25] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2023, 1954 (1) : 317 - 317
[26] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2023, 1952 (1) : 243 - 243
[27] OctreotideLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2021, 1859 (1) : 288 - 288
[28] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2023, 1940 (1) : 291 - 291
[29] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2021, 1886 (1) : 286 - 286
[30] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2022, 1896 (1) : 312 - 312

← 1 2 3 4 5 →